AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.
AFT Pharmaceuticals has expanded its global footprint by licensing Maxigesic IV, an innovative pain relief medicine, to Halex Istar in Brazil, a significant player in the hospital pharmaceutical sector. This partnership leverages Brazil’s status as South America’s largest and the world’s tenth largest pharmaceutical market, and aligns with AFT’s strategy to distribute its products worldwide, with Maxigesic IV now launched in 36 countries. The collaboration with Halex Istar is set to bolster the company’s presence in critical global markets, demonstrating AFT’s commitment to expanding its pharmaceutical distribution channels.
For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.
